Physician profile
Kaylar Howard
NPI 1912918327
$1,597.50
in general payments reported to CMS, 2019-2025
10 companies · $72.02 in 2025
The $72.02 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $12.53 · 2021: $459 · 2022: $477 · 2023: $398 · 2024: $52.23 · 2025: $72.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $448.74 | 2019-2023 | |
| Aspira Women'S Health INC | $350.70 | 2019-2021 | |
| Astellas Pharma US INC | $255.46 | 2019-2025 | Veozah, Myrbetriq |
| Medtronic, INC. | $158.91 | 2023 | Interstim |
| Axonics, INC. | $128.64 | 2022 | |
| Novo Nordisk INC | $121.60 | 2023 | Wegovy |
| Coopersurgical, INC. | $41.34 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $40.27 | 2022 | |
| Hologic Sales and Service, LLC | $29.08 | 2023-2024 | Aptima |
| Pacira Pharmaceuticals Incorporated | $22.76 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaylar Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.